Parkinson's disease is a common neurodegenerative disorder in which gastrointestinal
symptoms may appear prior to motor symptoms. The gut microbiota of patients with …

Background & aims Lifestyle interventions that focus on reduced energy intake and
improved dietary pattern are the mainstay of non-alcoholic fatty liver disease (NAFLD) …

Non-alcoholic fatty liver disease (NAFLD) and metabolic syndrome (MS) are two different
entities sharing common clinical and physio-pathological features, with insulin resistance …

In many countries worldwide, the burden of hepatocellular carcinoma (HCC) associated with
non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) is …

Non-alcoholic fatty liver disease (NAFLD) is a major health issue worldwide, frequently
associated with obesity and type 2 diabetes. Steatosis is the initial stage of the disease …

Background: With no approved pharmacotherapy to date, the present therapeutic
cornerstone for non-alcoholic fatty liver diseases (NAFLD) is a lifestyle intervention …

Meat is an important component of the human diet, and the consumption of processed meat
is high, despite the increasing popularity of the vegetarian model of nutrition. Both meat and …

Objectives Parkinson's disease (PD) is the second most common neurodegenerative
disorder. It is proposed that adherence to the Mediterranean diet might have a beneficial …

Metabolic syndrome, also as known as Syndrome X or Insulin Resistance Syndrome, is a
complex health problem featuring visceral obesity (the main diagnostic criterion), insulin …

Background & Aims The association of nonalcoholic fatty liver disease (NAFLD) with dietary
factors is well established but not thoroughly investigated. This systematic review and meta …